高级检索
当前位置: 首页 > 详情页

Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen-activated protein kinase signaling pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Yixing Peoples Hosp, Dept Pediat, Yixing, Peoples R China [2]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Shanghai, Peoples R China [3]Jinling Hosp, Dept Pediat, Nanjing, Peoples R China [4]Bayray Innovat Ctr, Shenzhen Bay Lab, Shenzhen, Peoples R China [5]Shanghai Jiao Tong Univ, Tongren Hosp, Hongqiao Int Inst Med, Sch Med, 720 Xianxia Rd, Shanghai 200336, Peoples R China [6]Yixing Peoples Hosp, Dept Pediat, 75 Tongzhenguan Rd, Yixing 214200, Jiangsu, Peoples R China
出处:
ISSN:

关键词: adipogenesis human primary visceral preadipocytes MAPK MetO obesity

摘要:
In this study, methionine sulfoxide (MetO) was identified as an active metabolite that suppresses adipogenesis after screening obese individuals versus the normal population. MetO suppressed the gene and protein expression of CCAAT/enhancer binding protein (C/EBP) alpha, adipocyte fatty acid binding protein 4 (FABP4), and the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) during human preadipocyte (HPA) differentiation. Adipogenesis decreased following MetO treatment; however, the preadipocyte number, proliferation, and apoptosis were unaffected. The activity of phosphorylated extracellular signal-related kinase (P-ERK) of the mitogen-activated protein kinase (MAPK) pathway was significantly inhibited in HPA after MetO treatment. Furthermore, treatment of preadipocytes with the selective P-ERK1/2 agonist Ro 67-7476 abolished the effect of MetO against adipogenesis suggesting that MetO function is dependent on the MAPK pathway. The mechanistic insights of adipogenesis suppression by MetO presented in this study shows its potential as an antiobesity drug.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 4 区 生物学
小类 | 4 区 细胞生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学
JCR分区:
出版当年[2021]版:
Q3 CELL BIOLOGY
最新[2023]版:
Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Yixing Peoples Hosp, Dept Pediat, Yixing, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Yixing Peoples Hosp, Dept Pediat, Yixing, Peoples R China [2]Shanghai Jiao Tong Univ, Tongren Hosp, Sch Med, Shanghai, Peoples R China [5]Shanghai Jiao Tong Univ, Tongren Hosp, Hongqiao Int Inst Med, Sch Med, 720 Xianxia Rd, Shanghai 200336, Peoples R China [6]Yixing Peoples Hosp, Dept Pediat, 75 Tongzhenguan Rd, Yixing 214200, Jiangsu, Peoples R China [*1]Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No.720 Xianxia Rd, Shanghai 200336, China. [*2]Department of Pediatrics, Yixing People's Hospital, No.75 Tongzhenguan Rd, Yixing, Jiangsu 214200, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23549 今日访问量:0 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)